Malignant Bile Duct Neoplasm — Trials

Malignant Bile Duct Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

883 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 223
Recruiting: 126
Ph III recruiting: 7
Growth YoY: +14.6%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (119)

clinicaltrialsPublishedShowing 251–290 of 290 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06717464	Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer	active not recruiting	Phase 2	110	Tianjin Medical University Cancer Institute and HospitalOTHER	1	Dec 5, 2024	clinicaltrials
NCT06711211	Spanish Registry of Digestive Tumours RETUD(RETUD)	recruiting	—	20,000	Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)